Literature DB >> 1501526

Evaluation of the susceptibility effect on gradient echo phase images in vivo: a sequential study of intracerebral hematoma.

N Yamada1, S Imakita, T Nishimura, M Takamiya, H Naito.   

Abstract

Susceptibility effect of intracerebral hematoma was estimated on the phase images of gradient echo (GrE). Thirty-five hematomas were studied 3 hr to 5 yr after the onset, a total of 72 times with use of phase and magnitude images of GrE, as well as T1-, T2-, and density-weighted spin-echo (SE) images at 1.5 T. On the basis of the theory of electromagnetism, phase shift to hematoma was calculated for simplified models with concentric distribution of paramagnetic susceptibility. All hematomas were well visualized by the phase images, the pattern of which changed sequentially. The distribution of paramagnetic susceptibility could be estimated by correlating the observed phase shifts with the calculated one. SE images were necessary to presume the type of magnetic substances. A probable hypothesis of the evolution of intracerebral hematoma is proposed.

Entities:  

Mesh:

Year:  1992        PMID: 1501526     DOI: 10.1016/0730-725x(92)90007-m

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  2 in total

1.  Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging.

Authors:  Simon P Robinson; Tammy L Kalber; Franklyn A Howe; Dominick J O McIntyre; John R Griffiths; David C Blakey; Lynsey Whittaker; Anderson J Ryan; John C Waterton
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

2.  Spontaneous Spongiform Brainstem Degeneration in a Young Mouse Lemur (Microcebus murinus) with Conspicuous Behavioral, Motor, Growth, and Ocular Pathologies.

Authors:  Daniel Schmidtke; Charlotte Lempp; Marko Dubicanac; Ute Radespiel; Elke Zimmermann; Wolfgang Baumgärtner; Sabine Kästner; Martin Meier; Anne Balkema-Buschmann; R Alan Harris; Muthuswamy Raveendran; Donna M Muzny; Kim C Worley; Jeffrey Rogers
Journal:  Comp Med       Date:  2018-11-28       Impact factor: 0.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.